U.S. flag

An official website of the United States government

NM_000335.5(SCN5A):c.3048G>A (p.Thr1016=) AND Cardiovascular phenotype

Germline classification:
Benign (1 submission)
Last evaluated:
Dec 1, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002444734.9

Allele description [Variation Report for NM_000335.5(SCN5A):c.3048G>A (p.Thr1016=)]

NM_000335.5(SCN5A):c.3048G>A (p.Thr1016=)

Genes:
LOC110121269:VISTA enhancer hs2177 [Gene]
SCN5A:sodium voltage-gated channel alpha subunit 5 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p22.2
Genomic location:
Preferred name:
NM_000335.5(SCN5A):c.3048G>A (p.Thr1016=)
Other names:
p.T1016T:ACG>ACA
HGVS:
  • NC_000003.12:g.38581111C>T
  • NG_008934.1:g.73562G>A
  • NG_053884.1:g.2850C>T
  • NM_000335.5:c.3048G>AMANE SELECT
  • NM_001099404.1:c.3048G>A
  • NM_001099404.2:c.3048G>A
  • NM_001099405.2:c.3048G>A
  • NM_001160160.2:c.3048G>A
  • NM_001160161.2:c.3048G>A
  • NM_001354701.2:c.3048G>A
  • NM_198056.3:c.3048G>A
  • NP_000326.2:p.Thr1016=
  • NP_001092874.1:p.Thr1016=
  • NP_001092875.1:p.Thr1016=
  • NP_001153632.1:p.Thr1016=
  • NP_001153633.1:p.Thr1016=
  • NP_001341630.1:p.Thr1016=
  • NP_932173.1:p.Thr1016=
  • NP_932173.1:p.Thr1016=
  • LRG_289t1:c.3048G>A
  • LRG_289t3:c.3048G>A
  • LRG_289:g.73562G>A
  • LRG_289p1:p.Thr1016=
  • NC_000003.11:g.38622602C>T
  • NM_198056.2:c.3048G>A
Links:
dbSNP: rs376734571
NCBI 1000 Genomes Browser:
rs376734571
Molecular consequence:
  • NM_000335.5:c.3048G>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001099404.2:c.3048G>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001099405.2:c.3048G>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001160160.2:c.3048G>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001160161.2:c.3048G>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001354701.2:c.3048G>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_198056.3:c.3048G>A - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Name:
Cardiovascular phenotype
Identifiers:
MedGen: CN230736

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002753538Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Benign
(Dec 1, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Genetic Analysis of SCN5A in Korean Patients Associated with Atrioventricular Conduction Block.

Park HS, Kim YN, Lee YS, Jung BC, Lee SH, Shin DG, Cho Y, Bae MH, Han SM, Lee MH.

Genomics Inform. 2012 Jun;10(2):110-6. doi: 10.5808/GI.2012.10.2.110. Epub 2012 Jun 30.

PubMed [citation]
PMID:
23105938
PMCID:
PMC3480677

Details of each submission

From Ambry Genetics, SCV002753538.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 9, 2024